[Intrahepatic biliary cystadenoma: case report]
G P Cione1, D Cerbone, A Di Benedetto
1ASL NA 1, PO San Giovanni Bosco, UOC di Chirurgia Generale d'Urgenza, Napoli.
Summary
Biliary cystadenoma (BCA) is a rare liver neoplasm with potential for malignant transformation and recurrence. Accurate diagnosis and complete surgical excision, often requiring hepatectomy, are crucial for patient management.
Area of Science:
- Hepatology
- Surgical Oncology
- Gastroenterology
Background:
- Liver adenomas are the most significant group of benign epithelial neoplasms of the liver, with increased incidence reported in women linked to oral contraceptive use.
- Biliary cystadenoma (BCA) is a rare liver neoplasm originating intrahepatically or, less commonly, from the extrahepatic biliary system.
Observation:
- BCA poses diagnostic challenges due to its similarity to other cystic liver lesions.
- The potential for malignant evolution and high recurrence rate underscore the surgical significance of BCA.
Findings:
- Complete surgical excision is necessary for BCA management.
- Radical excision often necessitates a formal hepatectomy.
Implications:
- Accurate differential diagnosis of cystic liver lesions is critical.
- Timely and complete surgical resection is essential to prevent recurrence and malignant transformation of BCAs.
- Understanding the behavior of BCAs informs surgical planning and patient prognosis.
